본문으로 건너뛰기
← 뒤로

[Updates in marginal zone lymphomas].

1/5 보강
Annales de pathologie 2026 OA
Retraction 확인
출처

Donzel M, Baseggio L, Laurent C, Xerri L, Pesce F, Traverse-Glehen A

📝 환자 설명용 한 줄

Five marginal zone lymphoma (MZL) entities are recognized and delineated in the 2022 WHO and ICC classifications: (i) extranodal marginal zone lymphoma (LZME), also known as mucosa-associated lymphoid

이 논문을 인용하기

↓ .bib ↓ .ris
APA Donzel M, Baseggio L, et al. (2026). [Updates in marginal zone lymphomas].. Annales de pathologie. https://doi.org/10.1016/j.annpat.2026.02.001
MLA Donzel M, et al.. "[Updates in marginal zone lymphomas].." Annales de pathologie, 2026.
PMID 41720645 ↗

Abstract

Five marginal zone lymphoma (MZL) entities are recognized and delineated in the 2022 WHO and ICC classifications: (i) extranodal marginal zone lymphoma (LZME), also known as mucosa-associated lymphoid tissue (MALT) lymphoma; (ii) nodal marginal zone lymphoma (NMZL); (iii) splenic marginal zone lymphoma (SMZL); (iv) pediatric nodal marginal zone lymphoma (PNMZL); and (v) primary cutaneous marginal zone lymphoma/lymphoproliferative disorder (PC-MZL). Although certain morphological, immunophenotypic, and genetic features are shared among the different subtypes, each entity displays distinct characteristics. This review focuses on the newly delineated cutaneous and pediatric entities, as well as recent molecular data that may help in the diagnosis of MZL.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (2)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기